Related Experiment Videos
Malignant tumours of the small bowel
1Mayo Clinic, Rochester, MN 55905.
Surgical Oncology
|April 1, 1994
Summary
Early diagnosis and surgical resection are key for small intestinal cancers. Improving detection and treatment of these rare tumors, including adenocarcinomas, carcinoids, lymphomas, and sarcomas, can enhance patient outcomes.
Area of Science:
- Gastroenterology and Oncology
- Surgical Oncology
Background:
- Small intestinal cancers are rare but require early diagnosis for optimal cure rates.
- Vague abdominal complaints warrant consideration of small bowel tumors in differential diagnosis.
- The small bowel is often a diagnostic blind spot for routine endoscopic and radiological evaluations.
Purpose of the Study:
- To highlight the importance of early diagnosis and surgical management of small intestinal malignancies.
- To discuss the diagnostic challenges and therapeutic strategies for various small bowel tumors.
- To emphasize the need for a high index of suspicion in detecting these rare cancers.
Main Methods:
- Review of diagnostic challenges in small intestinal cancers.
- Discussion of current therapeutic mainstays, including surgical resection.
- Exploration of potential impacts of advances in chemotherapy and combined modality therapy.
Main Results:
- Early diagnosis and surgical resection offer the best chance of cure for small intestinal cancers.
- Adenocarcinomas may benefit from advances in large bowel carcinoma chemotherapy.
- Carcinoid tumors offer palliation but have a poor long-term outlook; early lymphomas are treatable, advanced ones are resistant.
- Small bowel sarcoma prognosis depends on tumor grade.
Conclusions:
- A high index of suspicion is crucial for improving tumor detection rates.
- Enhanced diagnostic approaches for the small bowel are needed.
- Optimizing treatments based on histology and advancements in other anatomic sites can improve outcomes for small intestinal malignancies.